Germ line<i>DDX41</i>mutations define a unique subtype of myeloid neoplasms
Hideki Makishima(Kyoto University), Jaroslaw P. Maciejewski(Cleveland Clinic), Pramila Krishnamurthy(King's College London), Yasunobu Nagata(Kyoto University), Sophia C. Korotev(University of Chicago), Takayuki Ishikawa(Kobe City Medical Center General Hospital), Joop H. Jansen(Erasmus University Rotterdam), Akifumi Takaori‐Kondo(Kyoto University), Carsten Müller‐Tidow(University of Cologne), Ayana Kon(Kyoto University), Yotaro Ochi(Kyoto University), Toru Kiguchi(Chugoku Central Hospital), Hisashi Tsurumi(Matsunami General Hospital), Yuichi Shiraishi(The University of Tokyo), Kenichi Yoshida(Meiji University), Ryunosuke Saiki(Kyoto University), Masashi Sanada(Nagoya Medical Center), Fumihiko Matsuda(Kyoto University), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Kenichi Chiba(The University of Tokyo), Austin Kulasekararaj(King's College London), Yoshiko Atsuta(Aichi Medical University), Takuto Mori(Kyoto University), Nobuyuki Kakiuchi(Kyoto University), Yuka Iijima‐Yamashita(Nagoya Medical Center), Mario Cazzola(University of Pavia), Masahiro Nakagawa(Columbia University Irving Medical Center), Kazuma Ohyashiki(Tokyo Medical University), Piers Blombery(Peter MacCallum Cancer Centre), June Takeda(Kyoto University), Rurika Okuda(Kyoto University), Carmelo Gurnari(University of Rome Tor Vergata), Senji Kasahara(Gifu Municipal Hospital), Lucy A. Godley(University of Chicago), Yasuhito Nannya(Kyoto University), Shigeru Chiba(University of Tsukuba), Akinori Yoda(Kyoto University), Yasushi Miyazaki(Nagasaki University), Luca Malcovati(University of Pavia), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Makoto Onizuka(Tokai University), Tetsuichi Yoshizato(Kyoto University), Chantana Polprasert(Chulalongkorn University), Satoru Miyano, Hiroko Tanaka(The University of Tokyo), Yusuke Shiozawa(Kyoto University), Yukihide Momozawa(University of Liège), Steve Best(King's College London), Hidehiro Itonaga(Nagasaki University)
Cited by 142
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.7k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k